← Patent-cliff monitor small molecule PONVORY PONESIMOD
Loss of exclusivity December 2044 latest FDA-listed patent expiry
Drug detail Brand name PONVORY Active ingredient PONESIMOD Strength 20MG Dosage form TABLET Route ORAL Modality Small molecule FDA approval March 2021 Marketing status RX
Listed patents Patent Expires Type 12728116 December 2044 use U-4610 11951097 October 2042 use U-3891 12336980 December 2035 use U-3103 10220023 December 2035 use U-3103 9062014 May 2032 substance, product RE43728 November 2029 substance, product
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.